Skip to main content

Table 3 Release kinetics data of CUR and PTX from the niosomal optimum formulae

From: Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy

Regression coefficient (R2)

Formulation code

Zero order

First order

Higuchi model

Hixson–Crowell model

F7 (CUR)

0.9709

0.8492

0.9979

0.9002

F7 (PTX)

0.9686

0.882

0.9992

0.9161

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us